The Top Threats Targeting Pharma and Life Sciences

Pharmaceutical and life sciences companies have always been attractive targets for attack because of their valuable investments in proprietary intellectual property. However, the coronavirus pandemic has dramatically increased the value of this data for attackers of all kinds – and the threats are spiking in new and unexpected ways as adversaries try to get their hands on it.

This white paper provides an overview of the most dangerous threats currently targeting pharmaceutical and life sciences companies and lays out how these organizations can enhance their cybersecurity strategy to be more dynamic no matter how threats may evolve.